GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Gallbladder and Pancreas/Genetic Variants Linked to Pancreatic IPMN Development

Genetic Variants Linked to Pancreatic IPMN Development

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated September 1, 2025

Quick Answer

The study identified genetic variants that are significantly linked to the development of pancreatic intraductal papillary mucinous neoplasms (IPMNs), which are cystic lesions in the pancreas that have the potential to progress into pancreatic adenocarcinoma. ### Key Findings: 1.


The study identified genetic variants that are significantly linked to the development of pancreatic intraductal papillary mucinous neoplasms (IPMNs), which are cystic lesions in the pancreas that have the potential to progress into pancreatic adenocarcinoma.

### Key Findings:

1. **Genome-Wide Association Analysis**:

  • Researchers analyzed genetic data from 68,931 individuals in the Mass General Brigham Biobank, including 2,525 individuals diagnosed with IPMNs.
  • The analysis focused on common single nucleotide variants (SNVs) with a frequency of at least 5%.

2. **Significant Genetic Locus**:

  • The study identified a significant genetic association on chromosome 19.
  • Two specific variants, **rs681343** and **rs601338**, were strongly linked to an increased risk of developing IPMNs.

3. **Validation**:

  • These findings were validated in an independent cohort of 5,014 individuals, further confirming the association between these variants and IPMN risk.

### Role of FUT2 Gene:

The variant **rs601338** occurs in a noncoding exon of the **fucosyltransferase 2 (FUT2)** gene. This variant introduces a **stop codon**, which halts the synthesis of the FUT2 protein. The FUT2 gene is critical for several biological functions:

  • **Enzyme Function**: FUT2 encodes an enzyme involved in the Lewis antigen system, which plays a role in determining blood group antigens and secretor status.
  • **Mucin Production**: The enzyme contributes to mucin synthesis, which is important for maintaining ductal homeostasis in the pancreas.
  • **Regulation of Tumor Markers**: FUT2 influences levels of tumor markers such as carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA 19-9), which are often elevated in pancreatic diseases.

### Biological Implications:

The study suggests that genetic variations in FUT2 contribute to the development of IPMNs by disrupting mucin synthesis and ductal homeostasis. This disruption may create a favorable environment for the formation of cystic lesions and potentially their malignant transformation.

### Conclusion:

The identification of FUT2 variants, particularly rs601338, provides a biologically plausible link between genetic variation, mucin production, and the pathogenesis of pancreatic neoplasms. These findings offer insights into the genetic underpinnings of IPMNs and may aid in the development of targeted screening strategies or therapeutic interventions for individuals at risk of pancreatic cancer.

Related Q&A

Ivonescimab Plus Gemcitabine–Cisplatin in Biliary Tract Cancer (BTC): Journal of Hepatology | July 2026

Introduction: Advanced biliary tract cancer (BTC) carries a poor prognosis, with limited improvements in survival despite the addition of immune checkpoint inhibitors to standard gemcitabine–cisplatin chemotherapy. This phase II trial evaluated ivonescimab, a novel PD-1/VEGF...

GLP-1 Receptor Agonists and Gallbladder Disease: UEG Journal | June 2026

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a cornerstone in the management of type 2 diabetes because of their excellent glycemic, cardiovascular, and weight-loss benefits. However, concerns remain regarding their potential association with...

Remnant Duct Dilatation Rarely Signals IPMN Recurrence : Ann Surg | Jun 2026

Introduction: Patients undergoing pancreatoduodenectomy for non invasive intraductal papillary mucinous neoplasm (IPMN) require long-term surveillance because of the risk of disease recurrence in the pancreatic remnant. New pancreatic duct (PD) dilatation is commonly detected during...

Post-Pancreatectomy Chyle Leak: Annals of Surgery | June 2026

• This study evaluated 1,063 patients undergoing pancreatic surgery; 11% developed conventionally defined chyle leak. • Most clinically relevant cases were grade B, while no grade C leaks were reported. • A minimally invasive surgical...

Immediate Necrosectomy Accelerates Recovery in Walled-Off Necrosis : Gastroenterology | Jul 2026

Introduction: Endoscopic ultrasound (EUS)-guided drainage has become the preferred minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Fatty Pancreas: A Hidden Burden in T2DM : Diabetes Res Clin Pract | June 2026

Introduction: Fatty pancreas disease (FPD), also known as intrapancreatic fat deposition, has emerged as an important metabolic condition closely linked to obesity, insulin resistance, and type 2 diabetes mellitus (T2DM). Although ectopic fat accumulation in...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer